Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines

The Italian Association of Medical Oncology (AIOM) has developed clinical practice guidelines for the treatment of patients with advanced non-small cell lung cancer (NSCLC). In the current paper a panel of AIOM experts in the field of thoracic malignancies discussed the available scientific evidence...

Full description

Saved in:
Bibliographic Details
Published in:Critical reviews in oncology/hematology 2020-02, Vol.146, p.102858-102858, Article 102858
Main Authors: Passiglia, F., Pilotto, S., Facchinetti, F., Bertolaccini, L., Del Re, M., Ferrara, R., Franchina, T., Malapelle, U., Menis, J., Passaro, A., Ramella, S., Rossi, G., Trisolini, R., Novello, S.
Format: Article
Language:English
Subjects:
Antineoplastic Agents - therapeutic use
Carcinoma, Non-Small-Cell Lung - drug therapy
Carcinoma, Non-Small-Cell Lung - pathology
Clinical practice guidelines
Humans
Italy
Lung Neoplasms - drug therapy
Lung Neoplasms - pathology
Medical Oncology - standards
Metastatic disease
Non-small cell lung cancer
Practice Guidelines as Topic
Recommendations
Societies, Medical
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Italian Association of Medical Oncology (AIOM) has developed clinical practice guidelines for the treatment of patients with advanced non-small cell lung cancer (NSCLC). In the current paper a panel of AIOM experts in the field of thoracic malignancies discussed the available scientific evidences, with the final aim of providing a summary of clinical recommendations, which may guide physicians in their current practice.
ISSN:1040-8428
1879-0461
DOI:10.1016/j.critrevonc.2019.102858